Kamada Ltd. (TLV:KMDA)
Israel · Delayed Price · Currency is ILS · Price in ILA 2,138.00
+39.00 (1.86%)
Jul 17, 2026, 1:44 PM IDT
Kamada Employees
Kamada had 462 employees as of December 31, 2025. The number of employees increased by 42 or 10.00% compared to the previous year.
Employees
462
Change (1Y)
42
Growth (1Y)
10.00%
Revenue / Employee
1.24M ILS
Profits / Employee
139.18K ILS
Market Cap
1.23B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 462 | 42 | 10.00% |
| Dec 31, 2024 | 420 | 42 | 11.11% |
| Dec 31, 2023 | 378 | -2 | -0.53% |
| Dec 31, 2022 | 380 | 25 | 7.04% |
| Dec 31, 2021 | 355 | -53 | -12.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Teva Pharmaceutical Industries | 32,842 |
| Rekah Pharmaceutical Industry | 390 |
| InterCure | 285 |
| Together Pharma | 210 |
| Seach Medical Group | 162 |
| Tikun Olam-Cannbit Pharmaceuticals | 4 |
Kamada News
- 6 days ago - Kamada (KMDA) Presents Promising Cytogam Study Results at Global Conference - GuruFocus
- 6 days ago - Kamada highlights Cytogam study results - TheFly
- 6 days ago - Kamada Highlights CYTOGAM® Study Results Presented at the 2026 ISHLT Annual Meeting - GlobeNewsWire
- 6 weeks ago - Kamada (KMDA) Receives FDA Nod for New Fluorescent Focus Inhibition Test - GuruFocus
- 6 weeks ago - Kamada Receives FDA Approval For In-House Rabies Virus Neutralization Testing Laboratory - Nasdaq
- 6 weeks ago - Kamada gets FDA approval for Rapid Fluorescent Focus Inhibition Test laboratory - TheFly
- 6 weeks ago - Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory - GlobeNewsWire
- 2 months ago - Kamada (KMDA) Q1 2026 Earnings Transcript - The Motley Fool